BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Minor PD. The polio-eradication programme and issues of the end game. J Gen Virol 2012;93:457-74. [PMID: 22128250 DOI: 10.1099/vir.0.036988-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Minor P. The polio endgame. Hum Vaccin Immunother. 2014;10:2106-2108. [PMID: 25608050 DOI: 10.4161/21645515.2014.981115] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
2 Minor PD. Live attenuated vaccines: Historical successes and current challenges. Virology 2015;479-480:379-92. [PMID: 25864107 DOI: 10.1016/j.virol.2015.03.032] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 29.5] [Reference Citation Analysis]
3 Fox H, Knowlson S, Minor PD, Macadam AJ. Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines. PLoS Pathog 2017;13:e1006117. [PMID: 28103317 DOI: 10.1371/journal.ppat.1006117] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
4 Vidor E. Poliovirus Vaccine–Inactivated. Plotkin's Vaccines. Elsevier; 2018. pp. 841-865.e10. [DOI: 10.1016/b978-0-323-35761-6.00047-x] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Drexler JF, Grard G, Lukashev AN, Kozlovskaya LI, Böttcher S, Uslu G, Reimerink J, Gmyl AP, Taty-Taty R, Lekana-Douki SE, Nkoghe D, Eis-Hübinger AM, Diedrich S, Koopmans M, Leroy EM, Drosten C. Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010. Proc Natl Acad Sci U S A 2014;111:12889-94. [PMID: 25136105 DOI: 10.1073/pnas.1323502111] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
6 Sanders BP, Oakes Ide L, van Hoek V, Liu Y, Marissen W, Minor PD, Wimmer E, Schuitemaker H, Custers JH, Macadam A, Cello J, Edo-Matas D. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV. Vaccine 2015;33:6611-6. [PMID: 26529068 DOI: 10.1016/j.vaccine.2015.10.091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li W, Yi L, Su J, Lu J, Zeng H, Guan D, Ma C, Zhang W, Xiao H, Li H, Zhang Y, Lin J, Ke C. Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China. BMC Infect Dis 2013;13:322. [PMID: 23855481 DOI: 10.1186/1471-2334-13-322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
8 Adeniji JA, Faleye TO. Impact of cell lines included in enterovirus isolation protocol on perception of nonpolio enterovirus species C diversity. J Virol Methods 2014;207:238-47. [PMID: 25064357 DOI: 10.1016/j.jviromet.2014.07.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
9 Ecale Zhou CL. S2M: A Stochastic Simulation Model of Poliovirus Genetic State Transition. Bioinform Biol Insights 2016;10:81-95. [PMID: 27385911 DOI: 10.4137/BBI.S38194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Faleye TOC, Adewumi MO, Japhet MO, David OM, Oluyege AO, Adeniji JA, Famurewa O. Non-polio enteroviruses in faeces of children diagnosed with acute flaccid paralysis in Nigeria. Virol J 2017;14:175. [PMID: 28899411 DOI: 10.1186/s12985-017-0846-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sanz-ramos M, Manno D, Kapambwe M, Ndumba I, Musonda KG, Bates M, Chibumbya J, Siame J, Monze M, Filteau S, Gompels UA. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine 2013;31:2042-9. [DOI: 10.1016/j.vaccine.2013.02.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
12 Minor PD. Polio vaccines and the eradication of poliomyelitis. Lancet 2012;380:454-5. [PMID: 22766208 DOI: 10.1016/S0140-6736(12)60921-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
13 Wilton T, Dunn G, Eastwood D, Minor PD, Martin J. Effect of formaldehyde inactivation on poliovirus. J Virol 2014;88:11955-64. [PMID: 25100844 DOI: 10.1128/JVI.01809-14] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
14 Yang D, Sun C, Gao R, Wang H, Liu W, Yu K, Zhou G, Zhao B, Yu L. A Temperature-Dependent Translation Defect Caused by Internal Ribosome Entry Site Mutation Attenuates Foot-and-Mouth Disease Virus: Implications for Rational Vaccine Design. J Virol 2020;94:e00990-20. [PMID: 32493820 DOI: 10.1128/JVI.00990-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Babiuk LA, Gerdts V. Future vaccines for a globalized world. Emerg Microbes Infect 2012;1:e4. [PMID: 26038417 DOI: 10.1038/emi.2012.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 Mohanty MC, Madkaikar MR, Desai M, Aluri J, Varose SY, Taur P, Sharma DK, Nalavade UP, Rane SV, Gupta M, Shabarish S, Dalvi A, Deshpande JM. Natural Clearance of Prolonged VDPV Infection in a Child With Primary Immunodeficiency Disorder. Front Immunol 2019;10:1567. [PMID: 31396204 DOI: 10.3389/fimmu.2019.01567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 O'Connell AK, Douam F. Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises. Vaccines (Basel) 2020;8:E36. [PMID: 31973073 DOI: 10.3390/vaccines8010036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hay SI, Battle KE, Pigott DM, Smith DL, Moyes CL, Bhatt S, Brownstein JS, Collier N, Myers MF, George DB, Gething PW. Global mapping of infectious disease. Philos Trans R Soc Lond B Biol Sci 2013;368:20120250. [PMID: 23382431 DOI: 10.1098/rstb.2012.0250] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 15.5] [Reference Citation Analysis]
19 Klitting R, Riziki T, Moureau G, Piorkowski G, Gould EA, de Lamballerie X. Exploratory re-encoding of yellow fever virus genome: new insights for the design of live-attenuated viruses. Virus Evol 2018;4:vey021. [PMID: 30057792 DOI: 10.1093/ve/vey021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Razum O, Müller O. Polio eradication: where are we now? Lancet 2013;382:1979. [PMID: 24332075 DOI: 10.1016/S0140-6736(13)62652-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Majumdar M, Klapsa D, Wilton T, Akello J, Anscombe C, Allen D, Mee ET, Minor PD, Martin J. Isolation of Vaccine-Like Poliovirus Strains in Sewage Samples From the United Kingdom. J Infect Dis 2018;217:1222-30. [PMID: 29309594 DOI: 10.1093/infdis/jix667] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
22 Stanley M. HPV vaccination in boys and men. Hum Vaccin Immunother 2014;10:2109-11. [PMID: 25424825 DOI: 10.4161/hv.29137] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 10.6] [Reference Citation Analysis]
23 Rodríguez-Díaz J, Mira-Pascual L, Collado MC, Endo A, Hyöty H, Mangani C, Maleta K, Ashorn P, Salminen S. Presence of human enteric viruses in the stools of healthy Malawian 6-month-old infants. J Pediatr Gastroenterol Nutr 2014;58:502-4. [PMID: 24141259 DOI: 10.1097/MPG.0000000000000215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Jubelt B, Lipton HL. Enterovirus/picornavirus infections. Handb Clin Neurol 2014;123:379-416. [PMID: 25015496 DOI: 10.1016/B978-0-444-53488-0.00018-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
25 Minor PD. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication. Methods Mol Biol 2016;1387:1-10. [PMID: 26983727 DOI: 10.1007/978-1-4939-3292-4_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
26 Shaghaghi M, Irannejad M, Abolhassani H, Shahmahmoodi S, Hamidieh AA, Soleyman-Jahi S, Yazdani R, Azizi G, Aghamohammadi A. Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature. J Clin Immunol 2018;38:610-6. [PMID: 29948575 DOI: 10.1007/s10875-018-0521-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Knowlson S, Burlison J, Giles E, Fox H, Macadam AJ, Minor PD. New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication. PLoS Pathog 2015;11:e1005316. [PMID: 26720150 DOI: 10.1371/journal.ppat.1005316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
28 Stanley M. HPV vaccination in boys and men. Human Vaccines & Immunotherapeutics 2014;10:2106-8. [DOI: 10.4161/hv.29138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
29 Ghafoor S, Sheikh N. Eradication and Current Status of Poliomyelitis in Pakistan: Ground Realities. J Immunol Res 2016;2016:6837824. [PMID: 27517055 DOI: 10.1155/2016/6837824] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
30 Griffin DW. The Quest for Extraterrestrial Life: What About the Viruses? Astrobiology 2013;13:774-83. [DOI: 10.1089/ast.2012.0959] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
31 Sun M, Li C, Xu W, Liao G, Li R, Zhou J, Li Y, Cai W, Yan D, Che Y, Ying Z, Wang J, Yang H, Ma Y, Ma L, Ji G, Shi L, Jiang S, Li Q. Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses. Clinical Infectious Diseases 2017;64:1317-25. [DOI: 10.1093/cid/cix110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]